Curaleaf 3Q 2026: Revenue $352.65M, Net income ($32.72M), EPS ($0.12) — 10-Q Summary

Curaleaf Holdings reported Q3 2026 revenue of $352.65M, up 10.9% YoY. Net loss narrowed to $32.72M, with EPS at ($0.12). Wholesale and international revenue grew, with 191 stores across 15 states by November 3.

Original reporting
Published Nov 3, 2026, 10:31 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 3, 2026, 10:42 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Curaleaf 3Q 2026: Revenue $352.65M, Net income ($32.72M), EPS ($0.12) — 10-Q Summary — source image
Decision brief

The 30-second read

$CURLFBullishHigh
01

Why it matters

The earnings release provides fresh data on revenue growth and loss narrowing, key for short‑term trading decisions.

02

Market read

First‑report earnings data likely to move the stock in after‑hours trading.

03

What to watch

International expansion costs and potential slowdown in wholesale demand may temper upside.

Relevance 7/10Novelty 8/10Timing: after-hours

Background

Curaleaf is a leading U.S. multi-state cannabis operator with growing international presence.

Company-level read

Ticker impact

$CURLFBullishHigh confidence
Context

Curaleaf Holdings reported Q3 2026 revenue of $352.65M, a 10.9% YoY increase, and narrowed net loss to $32.72M.

Expected impact

potential upside as market prices in improved earnings and loss reduction

Evidence & confidence

The company showed top-line growth and a significant reduction in net loss, which are fresh, material data likely to influence trader sentiment.

Market effects

Positive earnings may boost sentiment in the U.S. cannabis sector.

Improved results could support broader market perception of U.S. multi-state operators.

Limited to cannabis investors; no major macro impact.

Counterpoint

Despite earnings beat, ongoing regulatory risk and market saturation could keep the stock pressured.

Key entities

  • Curaleaf Holdings

    U.S. cannabis operator (ticker CURLF).

Related articles

$CURLFMedAI 8/10

Curaleaf Holdings Inc (CURLF) (Q3 2026) Earnings Call Highlights: Record $353 Million

Curaleaf reported Q3 2026 revenue of $353M, up 11% YoY, with adjusted gross margin down 190bps to 49%. German market price compression and operational disruptions impacted margins. Net loss was $37M. Q4 revenue guidance suggests 1-2% sequential growth. CEO Boris Jordan discussed potential bid improvements for Aurora and regulatory challenges. Capital expenditures are expected to be $80M, limiting free cash flow.

Med

Curaleaf Q3 Revenue Hits Record $352.7 Million as Margins Contract

Curaleaf Holdings reported Q3 2026 revenue of $352.7M, up 10.9% YoY, but margins contracted. Net loss was $37.4M. Domestic revenue rose 8% to $294M, while international revenue grew 28% to $58.7M. Adjusted EBITDA increased to $77.6M. The company aims for $150M in full-year operating cash flow, with $104.9M cash and $636.9M debt at Q3 end. It also pursued Aurora Cannabis acquisition.